Why Does DAM Capital See Significant Upside Potential In UPL?
Key Investment Highlights
According to DAM Capital, restructuring-related concerns have weighed on UPL's stock performance over recent quarters. However, the company's core operating businesses continue to demonstrate healthy growth and margin improvement.
Target Price: ₹870
View: Value unlocking potential remains underappreciated by the market.
Strong Growth Across Key Businesses
UPL's seed business, Advanta, continues to deliver robust growth with revenues expanding at more than 20%. The company's specialty chemicals platform, Superform Specialty Chemicals, reported an impressive 51% growth during the first quarter.
These growth rates highlight the strength of UPL's diversified business portfolio and demonstrate that several business segments are growing significantly faster than the broader agrochemical industry.
Margin Expansion Supports Earnings Growth
Q1 Revenue Growth: +10%
Q1 EBITDA Growth: +15%
The improvement in contribution margins indicates better operating efficiency and pricing discipline. EBITDA growth exceeding revenue growth suggests that profitability is improving at a faster pace than sales expansion.
Why DAM Capital Believes The Discount Is Excessive
DAM Capital estimates that the market is currently applying approximately a 61% holding company discount to UPL's valuation. The brokerage considers this discount excessive given the quality of assets retained by UPL.
Importantly, UPL continues to own its rapidly growing Superform business while also retaining key central capabilities and strategic assets that support future growth initiatives.
Potential Value Unlocking Catalysts
One of the most significant near-term triggers highlighted by DAM Capital is the potential Advanta IPO. A successful listing could help investors better understand the standalone value of the seed business and potentially reduce the holding company discount currently assigned by the market.
Additional catalysts could emerge from continued margin expansion, specialty chemicals growth, and further clarity regarding the company's restructuring initiatives.
Investor Takeaway
Read Free content at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Written by Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.











